These findings suggest that the identified nsSNPs destabilize EPCR by altering its structural dynamics and reducing its capacity to activate protein C. This provides mechanistic insight into how PROCR variation may contribute to thrombotic disorders and highlights the utility of in silico approaches for prioritizing potentially pathogenic variants. The gene discussed is PROCR; the disease is thrombotic disease.